Industrializing EV therapies

• Characterization of EV-based therapies
• Clinical manufacturing, loading and decoration technologies
• Productivity increases for competitive cost-of-goods
• Early assessment to build investor confidence

Speakers:

Marcos Langtry

Director, Commercial Development & Allogeneic Cell Therapy

Lonza